CD4 and myasthenia gravis: Unlike previous studies on the mechanisms of TCM formulations for MG [20, 54], this study innovatively elucidates the mechanism of action of JYBP in treating MG by inhibiting the differentiation of CD4+ T cells into Th17 cells.